|
Match
|
Document |
Document Title |
|
|
7605179 |
Napthoquinone derivatives as inhibitors of tau aggregation for the treatment of alzheimer's and related neurodegenerative disorders
Provided are napthoquinone-type compounds which can be used to modulate the aggregation of protein (e.g. tau) associated with neurodegenerative disease (e.g. Alzheimer's disease)....
|
|
|
7579494 |
Prevention of neutrophil recruitment
Aspirin (ASA) triggers a switch in the biosynthesis of lipid mediators, inhibiting prostanoid production and initiating 15-epi-lipoxin generation, through the acetylation of cyclooxygenase II.
|
|
|
7557141 |
Method of treating autoimmune diseases
A method of treating an autoimmune disease (for example, Systemic Lupus Erythematosus) comprises administering to the subject a treatment effective amount of a histone hyperacetylating agent, or a...
|
|
|
7514413 |
In-vivo energy depleting strategies for killing drug-resistant cancer cells
This invention also provides a method for treating a cancer subject comprising administering to the subject a combination of ATP-depleting agents at concentrations which deplete the ATP level to,...
|
|
|
7485315 |
Compositions comprising a compound of low solubility and a lipophilic amino acid derivative, uses thereof and process for dissolving a compound of low solubility
The invention relates to a process for dissolving at least one compound of low solubility in water, the said process comprising the essential step of mixing the compound of low solubility with at...
|
|
|
7482377 |
Pharmaceutical compositions and methods of treatment based on diclofenac
New pharmaceutical compositions for oral use containing diclofenac together with alkali metal bicarbonates in amounts of from 20 to 80 by weight with respect to diclofenac are described. These...
|
|
|
7439393 |
Phenethanolamine derivatives for treatment of respiratory diseases
The invention relates to 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino
]-1-hydroxyethyl}-2-(hydroxymethyl)phenol; and salts and solvates thereof, including those which are...
|
|
|
7435408 |
Porous particles comprising excipients for deep lung delivery
Improved porous particles for drug delivery to the pulmonary system, and methods for their synthesis and administration are provided. In a preferred embodiment, the porous particles are made of a...
|
|
|
7309755 |
Method of producing polycarbonate articles by rotation molding and rotation molded articles made by the method
A method for making a polycarbonate article is described wherein the article is made by rotation molding a melt polycarbonate having a weight average molecular weight from 25,000 to about 36,000....
|
|
|
7255882 |
Enkephalinase inhibitor and GABA precursor loading as anti-anxiety compositions
Benzodiazepine withdrawal induced anxiety is treated by administration of an enkephalinase inhibitor, and a gamma-aminobutyric acid (“GABA”) precursor, or an endorphin or enkephalin releaser....
|
|
|
7220779 |
Swine growth promoters and method of promoting swine growth
A pig growth enhancer, which comprises, as an active ingredient, at least one compound selected from 5-aminolevulinic acid, a derivative thereof and a salt thereof, and a method for enhancing pig...
|
|
|
7192940 |
Ether compounds
The present invention relates to novel ether compounds, compositions comprising ether compounds, and methods useful for treating and preventing cardiovascular diseases, dyslipidemias,...
|
|
|
7189747 |
Method of treating noninflammatory cartilage damage
The invention relates to a method of preventing or treating cartilage damage by administering a GABA analog such as, for example, a compound of Formula
and pharmaceutically acceptable salts...
|
|
|
7173019 |
Linked cyclitols and their polysulfated derivatives
The invention relates to compounds of the following formula (I). In these compounds, R 1 , R 2 , R 3 and R 4 are each independently a substituted or unsubstituted cyclitol with a ring comprising...
|
|
|
7169810 |
Guanidine and amidine acid derivatives and analogs and methods of using the same
The present invention releates to certain novel guanidine or amidine acid derivatives and analogs, to a process for preparing such compounds, having the utility in clinical conditions associated...
|
|
|
7153886 |
Method for treatment of peripheral inflammation of a loop ileal artificial anus
The present invention provides a novel agent for prophylaxis or treatment of inflammatory bowel diseases for oral administration or intra-intestinal infusion, which comprises as an active...
|
|
|
7067555 |
Sertraline oral concentrate
The present invention provides an essentially nonaqueous, liquid pharmaceutical concentrate composition for oral administration containing sertraline or a pharmaceutically acceptable salt thereof...
|
|
|
7056950 |
Compositions of biochemical compounds involved in bioenergy metabolism of cells
A composition of biochemical compounds involved in bioenergy metabolism of cells and a method of use in prevention and therapy of diseases are disclosed.
|
|
|
7053150 |
Segmented polymers and their conjugates
Segmented water soluble polymers, containing a higher molecular weight segment linked to a lower molecular weight segment, are described. In one embodiment, the polymer segments are poly(ethylene...
|
|
|
7037934 |
Blood lipid ameliorant composition
A blood lipid ameliorating composition containing atorvastatin in combination with an agent selected from the group consisting of a riboflavin derivative, a tocopherol compound, an ascorbic acid...
|
|
|
7030158 |
Therapeutic compounds
A group of new compounds, N-(all-trans-Retinoyl)-L-cysteic acid, N-(13-cis-Retinoyl)-L-cysteic acid, N-(all-trans-Retinoyl)-L-cysteinesulfinic acid, N-(13-cis-Retinoyl)-L-cysteinesulfinic acid,...
|
|
|
6994873 |
Multiparticulate formulations of lithium salts for oral administration suitable for once-a-day administration
This invention refers to:
multiparticulate formulations of Lithium salts for oral administration constituted by either modified release granules or mixtures of modified and conventional...
|
|
|
6989380 |
Treatment of pain
A method of treating pain by the co-administration of an antidepressant together with one or more precursors or inducers of neurotransmitters, particularly amino acids selected from...
|
|
|
6982097 |
Biocidal compositions and methods of using same
This invention relates to biocidal compositions and methods of using same. Also provided is a process for the manufacturing of a biocidal composition in the form of a tablet and a method of using...
|
|
|
6974595 |
Pharmaceutical compositions based on Diclofenae
New pharmaceutical compositions for oral use containing Diclofenac together with alkali metal bicarbonates in amounts of from 20 to 80 by weight with respect to Diclofenac are described. These...
|
|
|
6949250 |
Selective algaecides for control of cyanochloronta
We have now discovered that certain 9,10-anthraquinone derivatives we developed possess potent activity against O. perornata while possessing a sufficiently high level of solubility in water to...
|
|
|
6939566 |
Microbicidal formulations and methods to control microorganisms
Microbicidal formulations are described which are preferably ecologically friendly and non-toxic to mammals, and are highly effective against a broad spectrum of detrimental pathogenic...
|
|
|
6927223 |
Use of serotonin agents for adjunct therapy in the treatment of cancer
The invention provides a method for the treatment of cancer comprising administering a serotonin agent. Also provided is a method for the treatment of cachexia comprising administering a serotonin...
|
|
|
6926892 |
Protecting plants from oomycete pathogens by treatment with compositions containing serratamolide and oocydin a from Serratia marcescens
A method is provided to protect plants from oomycete pathogens by treating plants with a composition comprising serratamolide. The composition may also contain oocydin A obtained from Serratia...
|
|
|
6919376 |
Therapeutic agents and corresponding treatments
Compositions and methods of using an MT103 family member, wherein MT103 is the chemical N,N-dicyclohexyl-(1S)-isoborneol-10-sulfonamide. Uses of the compositions include cancer therapy,...
|
|
|
6911473 |
Detectable agent for wood treatment and method for its detection
The present invention relates to a composition comprising an organic preservative acid and a UV-active indicator substance for preserving wood and for detection of the sufficient preservation of wood.
|
|
|
6900245 |
Pharmaceutical composition comprising crystalline sibutramine methanesulfonate hemihydrate
The present invention relates to a pharmaceutical composition for treating or preventing obesity, comprising novel crystalline sibutramine methanesulfonate hemihydrate of formula (I). The...
|
|
|
6896908 |
Wood preservative concentrate
This invention relates to a leach-resistant borate preservative for lignocellulosic-based products, providing resistance against insect and fungal attack for use in exterior and ground contact...
|
|
|
6833359 |
Method for treating soil for the control of soil borne plant pathogens
A method for reducing bacterial and fungal soil pathogens which comprises applying to a soil a chemically effective amount of a lignosulfonate, the amount preferably being between 0.05% and about...
|
|
|
6824786 |
Compositions comprising phenyl-glycine derivatives
The invention relates to compositions and methods useful for treating a variety of cosmetic conditions and dermatological disorders, where the composition includes a phenyl glycine derivative...
|
|
|
6821508 |
Composition and method for topical nail treatment
The invention discloses a composition comprising a sulfur-containing glycine residue combined with urea to increase the permeation of an active agent or drug through human nail tissue. The...
|
|
|
6803399 |
Silicone liquid crystals, vesicles, and gels
Silicone liquid crystals, silicone vesicles, and silicone gels are formed by combining (i) an amine functional silicone or an organic amine compound, (ii) an organic epoxide containing at least two...
|
|
|
6803057 |
Hydrogen peroxide disinfectant with increased activity
An acidic aqueous hydrogen peroxide solution is provided with improved disinfectant activity. Concentrated solutions preferably contain up to about 8 wt./wt. % H2O2 and as-used concentrations...
|
|
|
6797284 |
Phytopharmaceutical food products or integrators
Phytopharmaceutical food products which contain plant extracts and aminoacids and which can be used in order to reduce tobacco smoke addiction.
|
|
|
6784208 |
Method for preventing and treating visceral pain and gastrointestinal disorders
The compounds of formula I-IV: wherein n is an integer of from 1 to 4, or pharmaceutically acceptable salts thereof are useful to prevent and treat visceral pain and gastrointestinal disorders.
|
|
|
6777445 |
Fullerene pharmaceutical compositions for preventing or treating disorders
The present invention relates to a method for treating a disease, comprising administering a therapeutically effective amount of a pharmaceutical composition comprising a fullerene. The diseases...
|
|
|
6774180 |
Synthesis of high molecular weight non-peptidic polymer derivatives
High molecular weight derivatives of activated poly(ethylene glycol) and the like polymers are prepared in high purity by conjugating a large PEG molecule to a small PEG molecule. Most of the...
|
|
|
6761912 |
Composition for increasing bone density
A composition and a method for administering an improved supplement to prevent bone density loss. The composition combines a calcium compound with inulin, and optionally magnesium, Vitamin D 3 ,...
|
|
|
6749869 |
Acidic aqueous chlorite teat dip providing shelf life, sanitizing capacity and tissue protection
The mastitis control teat dip composition of the invention provides rapid initial kill, a useful highly pseudoplastic rheology, a barrier/film-forming capacity, a unique antimicrobial composition...
|
|
|
6730702 |
Therapeutic agents for inflammatory diseases of intestine
The present invention provides a novel agent for prophylaxis or treatment of inflammatory bowel diseases for oral administration or intra-intestinal infusion, which comprises as an active...
|
|
|
6727283 |
Sertraline oral concentrate
The present invention provides an essentially nonaqueous, liquid pharmaceutical concentrate composition for oral administration containing sertraline or a pharmaceutically acceptable salt thereof...
|
|
|
6719988 |
Antiseptic compositions for inactivating prions
An antiseptic composition useful in destroying the infectivity of infectious proteins such as prions is disclosed. The antiseptic composition is preferably maintained at a pH of 4.0 or less which...
|
|
|
6710082 |
Use of hydroxycarboxylic acid esters as thickeners
A thickener composition containing a reaction product of a hydroxycarboxylic acid selected from the group consisting of tartaric acid, malic acid, citric acid and mixtures thereof, and a fatty...
|
|
|
6706743 |
β3 adrenergic receptor agonists and uses thereof
The instant invention provides β 3 adrenergic receptor agonists of structural Formula (I), the stereoisomers and prodrugs thereof, and the pharmaceutically acceptable salts of the compounds,...
|
|
|
6706290 |
Methods for eradication of nanobacteria
Nanobacteria contribute to pathological calcification in the human and animal body, including diseases such as kidney stones, salivary gland stones, dental pulp stones and atherosclerosis. The...
|